Blog
NET Research: Temporary Delays due to COVID
NETRF’s Director of Research John Kanki, PhD, provides an update on the status of ongoing NETRF-funded research studies during COVID-19.
May 13, 2020
No Comments
Category: For Researchers
About NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
Blog
Organoid Research Recognized at ENETS
NETRF-funded research of miniature replicas of human organs is recognized with a Presidential Award for Basic Science at ENETS, a leading international meeting of NET scientists.
May 11, 2020
1 Comment
Blog
Milestone Achievements Announced in NET Cell Line Development
NETRF reports progress in the development of neuroendocrine tumor cell lines to help eliminate a decades-old obstacle in laboratory research. To stimulate progress in NET cell lines, NETRF established a Cell Line Prize, funded cell line research, and launched a collaboration with a nationally known research institute. Each of these initiatives has succeeded in establishing NET cell lines.
March 11, 2020
No Comments
Blog
NETRF Welcomes New Members to its Board of Scientific Advisors
NETRF welcomes five new members to its Board of Scientific Advisors, a volunteer council of highly distinguished medical and research leaders who share NETRF’s commitment to advancing the diagnosis and treatment of neuroendocrine cancer.
March 11, 2020
No Comments
Blog
NETRF Awards $3.5 Million in Grants
Research to Advance Neuroendocrine Tumor Treatment The Neuroendocrine Tumor Research Foundation (NETRF) today announced $3.5 million in neuroendocrine tumor (NET) research grants to fund 12
February 10, 2020
1 Comment
Blog
Exploring new ground with a clinical trial of a NET cancer vaccine
A NETRF-funded clinical trial looks at a cancer vaccine called SurVaxM in neuroendocrine cancer to help slow or stop the spread of neuroendocrine tumors.
January 23, 2020
No Comments
Blog
NETRF-funded Research Included Among 2019’s Most Important Developments
Highlights from NANETS 2019 symposium where leading NET experts presented progress and identified priorities for moving NET knowledge and care forward.
October 22, 2019
No Comments
Blog
Delivering Chemotherapy Directly to Tumors
New grant explores precision drug delivery in NETs The American Association of Cancer Researchers (AACR) has awarded a NETRF-funded research grant to a Texas researcher
July 18, 2019
1 Comment
Blog
Finding May Help Predict Pancreatic NET Recurrence
NETRF-funded researchers identified a cancer cell type that is associated with non-functional pancreatic neuroendocrine tumor (pNET) recurrence. Alpha-like pNET cell expression of the protein ARX can guide prognosis.
July 1, 2019
No Comments
Blog
Grant Applications Go to Board of Scientific Advisors
NETRF’s Board of Scientific Advisors and external reviewers will begin reading and ranking the 2019 requests for research funding. Wide Range of Requests for NET
June 20, 2019
No Comments